
    
      This will be a retrospective four-cohort study. The four cohorts will be septic shock
      patients that were: 1) not on either a chronic β-blocker or chronic
      angiotensin-converting-enzyme inhibitor (ACE-Inhibitor), 2) on chronic β-blocker, 3) on
      ACE-Inhibitor, and 4) on both chronic β-blocker and ACE-inhibitor
    
  